Halozyme Therapeutics (NASDAQ:HALO) announced on Wednesday that it has agreed to acquire Elektrofi, Inc., a Boston-based company focused on drug delivery technology, for an upfront payment of $750M and additional milestone payments. Under the deal expected to close in Q4 ...